RAD18_HUMAN - dbPTM
RAD18_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RAD18_HUMAN
UniProt AC Q9NS91
Protein Name E3 ubiquitin-protein ligase RAD18
Gene Name RAD18
Organism Homo sapiens (Human).
Sequence Length 495
Subcellular Localization Nucleus . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Associates with chromatin (PubMed:25931565). Colocalizes with SLF1 in the nucleus and to centrosomes (PubMed:15632077). Relocalizes with SLF1 to nuclear foci in response t
Protein Description E3 ubiquitin-protein ligase involved in postreplication repair of UV-damaged DNA. Postreplication repair functions in gap-filling of a daughter strand on replication of damaged DNA. Associates to the E2 ubiquitin conjugating enzyme UBE2B to form the UBE2B-RAD18 ubiquitin ligase complex involved in mono-ubiquitination of DNA-associated PCNA on 'Lys-164'. Has ssDNA binding activity..
Protein Sequence MDSLAESRWPPGLAVMKTIDDLLRCGICFEYFNIAMIIPQCSHNYCSLCIRKFLSYKTQCPTCCVTVTEPDLKNNRILDELVKSLNFARNHLLQFALESPAKSPASSSSKNLAVKVYTPVASRQSLKQGSRLMDNFLIREMSGSTSELLIKENKSKFSPQKEASPAAKTKETRSVEEIAPDPSEAKRPEPPSTSTLKQVTKVDCPVCGVNIPESHINKHLDSCLSREEKKESLRSSVHKRKPLPKTVYNLLSDRDLKKKLKEHGLSIQGNKQQLIKRHQEFVHMYNAQCDALHPKSAAEIVREIENIEKTRMRLEASKLNESVMVFTKDQTEKEIDEIHSKYRKKHKSEFQLLVDQARKGYKKIAGMSQKTVTITKEDESTEKLSSVCMGQEDNMTSVTNHFSQSKLDSPEELEPDREEDSSSCIDIQEVLSSSESDSCNSSSSDIIRDLLEEEEAWEASHKNDLQDTEISPRQNRRTRAAESAEIEPRNKRNRN
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MDSLAESR
-------CCCHHHHC
7.7322814378
16UbiquitinationWPPGLAVMKTIDDLL
CCCCHHHHHHHHHHH
2.3621890473
17UbiquitinationPPGLAVMKTIDDLLR
CCCHHHHHHHHHHHH
35.4133845483
24UbiquitinationKTIDDLLRCGICFEY
HHHHHHHHCCCCHHH
24.7423000965
29UbiquitinationLLRCGICFEYFNIAM
HHHCCCCHHHCCEEE
8.9023000965
41UbiquitinationIAMIIPQCSHNYCSL
EEEECHHCCCCCHHH
3.6127667366
52AcetylationYCSLCIRKFLSYKTQ
CHHHHHHHHHHCCCC
30.6426051181
52UbiquitinationYCSLCIRKFLSYKTQ
CHHHHHHHHHHCCCC
30.6421963094
55PhosphorylationLCIRKFLSYKTQCPT
HHHHHHHHCCCCCCC
27.9328152594
56PhosphorylationCIRKFLSYKTQCPTC
HHHHHHHCCCCCCCE
21.8725884760
57AcetylationIRKFLSYKTQCPTCC
HHHHHHCCCCCCCEE
28.8326051181
57UbiquitinationIRKFLSYKTQCPTCC
HHHHHHCCCCCCCEE
28.8321963094
58PhosphorylationRKFLSYKTQCPTCCV
HHHHHCCCCCCCEEE
27.4628152594
62PhosphorylationSYKTQCPTCCVTVTE
HCCCCCCCEEEEECC
26.6028152594
65UbiquitinationTQCPTCCVTVTEPDL
CCCCCEEEEECCCCC
5.4023000965
66PhosphorylationQCPTCCVTVTEPDLK
CCCCEEEEECCCCCC
14.0628152594
68UbiquitinationPTCCVTVTEPDLKNN
CCEEEEECCCCCCCC
32.2223000965
70UbiquitinationCCVTVTEPDLKNNRI
EEEEECCCCCCCCHH
42.7523000965
73UbiquitinationTVTEPDLKNNRILDE
EECCCCCCCCHHHHH
60.6021963094
75UbiquitinationTEPDLKNNRILDELV
CCCCCCCCHHHHHHH
30.6823000965
82UbiquitinationNRILDELVKSLNFAR
CHHHHHHHHHHHHHH
3.5822817900
83UbiquitinationRILDELVKSLNFARN
HHHHHHHHHHHHHHH
62.9523000965
84UbiquitinationILDELVKSLNFARNH
HHHHHHHHHHHHHHH
22.5222817900
99PhosphorylationLLQFALESPAKSPAS
HHHHHHHCCCCCCCC
30.8922167270
100UbiquitinationLQFALESPAKSPASS
HHHHHHCCCCCCCCC
34.0423000965
102SumoylationFALESPAKSPASSSS
HHHHCCCCCCCCCCC
61.43-
102SumoylationFALESPAKSPASSSS
HHHHCCCCCCCCCCC
61.43-
102UbiquitinationFALESPAKSPASSSS
HHHHCCCCCCCCCCC
61.4321963094
103PhosphorylationALESPAKSPASSSSK
HHHCCCCCCCCCCCC
28.0123927012
106PhosphorylationSPAKSPASSSSKNLA
CCCCCCCCCCCCCEE
33.8526503892
107PhosphorylationPAKSPASSSSKNLAV
CCCCCCCCCCCCEEE
40.5123927012
108PhosphorylationAKSPASSSSKNLAVK
CCCCCCCCCCCEEEE
42.7223927012
109PhosphorylationKSPASSSSKNLAVKV
CCCCCCCCCCEEEEE
27.7523927012
110SumoylationSPASSSSKNLAVKVY
CCCCCCCCCEEEEEE
58.91-
110SumoylationSPASSSSKNLAVKVY
CCCCCCCCCEEEEEE
58.91-
110UbiquitinationSPASSSSKNLAVKVY
CCCCCCCCCEEEEEE
58.9123000965
111UbiquitinationPASSSSKNLAVKVYT
CCCCCCCCEEEEEEC
34.8723000965
115SumoylationSSKNLAVKVYTPVAS
CCCCEEEEEECCCCC
24.74-
115SumoylationSSKNLAVKVYTPVAS
CCCCEEEEEECCCCC
24.74-
115UbiquitinationSSKNLAVKVYTPVAS
CCCCEEEEEECCCCC
24.7423000965
117PhosphorylationKNLAVKVYTPVASRQ
CCEEEEEECCCCCHH
10.2928796482
118PhosphorylationNLAVKVYTPVASRQS
CEEEEEECCCCCHHH
17.8025159151
122PhosphorylationKVYTPVASRQSLKQG
EEECCCCCHHHHHHC
30.9625159151
125PhosphorylationTPVASRQSLKQGSRL
CCCCCHHHHHHCCCH
36.1025159151
127SumoylationVASRQSLKQGSRLMD
CCCHHHHHHCCCHHH
58.84-
127SumoylationVASRQSLKQGSRLMD
CCCHHHHHHCCCHHH
58.84-
127UbiquitinationVASRQSLKQGSRLMD
CCCHHHHHHCCCHHH
58.8427667366
130O-linked_GlycosylationRQSLKQGSRLMDNFL
HHHHHHCCCHHHHHH
21.5330379171
132UbiquitinationSLKQGSRLMDNFLIR
HHHHCCCHHHHHHHH
5.6021963094
141SulfoxidationDNFLIREMSGSTSEL
HHHHHHHCCCCHHHH
3.8521406390
142PhosphorylationNFLIREMSGSTSELL
HHHHHHCCCCHHHHH
25.4925159151
144PhosphorylationLIREMSGSTSELLIK
HHHHCCCCHHHHHHH
22.8128555341
145PhosphorylationIREMSGSTSELLIKE
HHHCCCCHHHHHHHH
29.7326074081
146PhosphorylationREMSGSTSELLIKEN
HHCCCCHHHHHHHHC
28.1326074081
151SumoylationSTSELLIKENKSKFS
CHHHHHHHHCHHCCC
56.03-
151SumoylationSTSELLIKENKSKFS
CHHHHHHHHCHHCCC
56.03-
151UbiquitinationSTSELLIKENKSKFS
CHHHHHHHHCHHCCC
56.0323000965
153UbiquitinationSELLIKENKSKFSPQ
HHHHHHHCHHCCCCC
49.2323000965
154UbiquitinationELLIKENKSKFSPQK
HHHHHHCHHCCCCCC
56.9923000965
155PhosphorylationLLIKENKSKFSPQKE
HHHHHCHHCCCCCCC
50.9830266825
155UbiquitinationLLIKENKSKFSPQKE
HHHHHCHHCCCCCCC
50.9823000965
156UbiquitinationLIKENKSKFSPQKEA
HHHHCHHCCCCCCCC
52.0123000965
158PhosphorylationKENKSKFSPQKEASP
HHCHHCCCCCCCCCC
30.1123401153
159UbiquitinationENKSKFSPQKEASPA
HCHHCCCCCCCCCCC
53.0121890473
161UbiquitinationKSKFSPQKEASPAAK
HHCCCCCCCCCCCCC
59.6423000965
164O-linked_GlycosylationFSPQKEASPAAKTKE
CCCCCCCCCCCCCCC
19.0330379171
164PhosphorylationFSPQKEASPAAKTKE
CCCCCCCCCCCCCCC
19.0323401153
168UbiquitinationKEASPAAKTKETRSV
CCCCCCCCCCCCCCH
63.3421906983
169PhosphorylationEASPAAKTKETRSVE
CCCCCCCCCCCCCHH
29.4129449344
170UbiquitinationASPAAKTKETRSVEE
CCCCCCCCCCCCHHH
57.2822817900
171UbiquitinationSPAAKTKETRSVEEI
CCCCCCCCCCCHHHH
55.4722817900
172PhosphorylationPAAKTKETRSVEEIA
CCCCCCCCCCHHHHC
29.7825627689
172UbiquitinationPAAKTKETRSVEEIA
CCCCCCCCCCHHHHC
29.7822817900
173UbiquitinationAAKTKETRSVEEIAP
CCCCCCCCCHHHHCC
39.5322817900
174PhosphorylationAKTKETRSVEEIAPD
CCCCCCCCHHHHCCC
41.1020873877
175UbiquitinationKTKETRSVEEIAPDP
CCCCCCCHHHHCCCH
7.4421963094
185UbiquitinationIAPDPSEAKRPEPPS
HCCCHHHCCCCCCCC
19.9321890473
186SumoylationAPDPSEAKRPEPPST
CCCHHHCCCCCCCCC
65.52-
186SumoylationAPDPSEAKRPEPPST
CCCHHHCCCCCCCCC
65.52-
186UbiquitinationAPDPSEAKRPEPPST
CCCHHHCCCCCCCCC
65.5223000965
190UbiquitinationSEAKRPEPPSTSTLK
HHCCCCCCCCCCCCC
30.7222817900
192PhosphorylationAKRPEPPSTSTLKQV
CCCCCCCCCCCCCCC
45.7828555341
194PhosphorylationRPEPPSTSTLKQVTK
CCCCCCCCCCCCCCC
35.7625627689
195PhosphorylationPEPPSTSTLKQVTKV
CCCCCCCCCCCCCCC
37.7525627689
197SumoylationPPSTSTLKQVTKVDC
CCCCCCCCCCCCCCC
42.69-
197SumoylationPPSTSTLKQVTKVDC
CCCCCCCCCCCCCCC
42.69-
197UbiquitinationPPSTSTLKQVTKVDC
CCCCCCCCCCCCCCC
42.6923000965
201SumoylationSTLKQVTKVDCPVCG
CCCCCCCCCCCCCCC
36.90-
201SumoylationSTLKQVTKVDCPVCG
CCCCCCCCCCCCCCC
36.90-
201UbiquitinationSTLKQVTKVDCPVCG
CCCCCCCCCCCCCCC
36.9023000965
218UbiquitinationIPESHINKHLDSCLS
CCHHHHHHHHHHHCC
44.9621906983
223UbiquitinationINKHLDSCLSREEKK
HHHHHHHHCCHHHHH
3.9023000965
229SumoylationSCLSREEKKESLRSS
HHCCHHHHHHHHHHH
58.02-
229SumoylationSCLSREEKKESLRSS
HHCCHHHHHHHHHHH
58.02-
229UbiquitinationSCLSREEKKESLRSS
HHCCHHHHHHHHHHH
58.02-
232UbiquitinationSREEKKESLRSSVHK
CHHHHHHHHHHHHHC
37.6523000965
235PhosphorylationEKKESLRSSVHKRKP
HHHHHHHHHHHCCCC
41.8425627689
236PhosphorylationKKESLRSSVHKRKPL
HHHHHHHHHHCCCCC
23.0828348404
239UbiquitinationSLRSSVHKRKPLPKT
HHHHHHHCCCCCCHH
61.0223000965
241AcetylationRSSVHKRKPLPKTVY
HHHHHCCCCCCHHHH
56.5626051181
241UbiquitinationRSSVHKRKPLPKTVY
HHHHHCCCCCCHHHH
56.5623000965
242UbiquitinationSSVHKRKPLPKTVYN
HHHHCCCCCCHHHHH
58.9123000965
245UbiquitinationHKRKPLPKTVYNLLS
HCCCCCCHHHHHHCC
59.3023000965
247UbiquitinationRKPLPKTVYNLLSDR
CCCCCHHHHHHCCCH
3.5823000965
254MethylationVYNLLSDRDLKKKLK
HHHHCCCHHHHHHHH
48.03115490091
255UbiquitinationYNLLSDRDLKKKLKE
HHHCCCHHHHHHHHH
68.7623000965
257SumoylationLLSDRDLKKKLKEHG
HCCCHHHHHHHHHCC
52.75-
257SumoylationLLSDRDLKKKLKEHG
HCCCHHHHHHHHHCC
52.75-
257UbiquitinationLLSDRDLKKKLKEHG
HCCCHHHHHHHHHCC
52.7521906983
258UbiquitinationLSDRDLKKKLKEHGL
CCCHHHHHHHHHCCC
71.3123000965
259UbiquitinationSDRDLKKKLKEHGLS
CCHHHHHHHHHCCCC
64.3023000965
261SumoylationRDLKKKLKEHGLSIQ
HHHHHHHHHCCCCCC
57.45-
261SumoylationRDLKKKLKEHGLSIQ
HHHHHHHHHCCCCCC
57.45-
261UbiquitinationRDLKKKLKEHGLSIQ
HHHHHHHHHCCCCCC
57.4523000965
271UbiquitinationGLSIQGNKQQLIKRH
CCCCCCCHHHHHHHH
46.3627667366
276UbiquitinationGNKQQLIKRHQEFVH
CCHHHHHHHHHHHHH
53.0422817900
284UbiquitinationRHQEFVHMYNAQCDA
HHHHHHHHHHHCCCC
2.0121890473
290UbiquitinationHMYNAQCDALHPKSA
HHHHHCCCCCCCCCH
39.8321963094
297UbiquitinationDALHPKSAAEIVREI
CCCCCCCHHHHHHHH
18.4221963094
309UbiquitinationREIENIEKTRMRLEA
HHHHHHHHHHHHHHH
37.3223000965
318SumoylationRMRLEASKLNESVMV
HHHHHHHHCCCCEEE
63.48-
318SumoylationRMRLEASKLNESVMV
HHHHHHHHCCCCEEE
63.48-
318UbiquitinationRMRLEASKLNESVMV
HHHHHHHHCCCCEEE
63.4823000965
322PhosphorylationEASKLNESVMVFTKD
HHHHCCCCEEEEECC
17.9130266825
327PhosphorylationNESVMVFTKDQTEKE
CCCEEEEECCCCHHH
23.4630266825
328SumoylationESVMVFTKDQTEKEI
CCEEEEECCCCHHHH
36.05-
328SumoylationESVMVFTKDQTEKEI
CCEEEEECCCCHHHH
36.05-
328UbiquitinationESVMVFTKDQTEKEI
CCEEEEECCCCHHHH
36.0523000965
333UbiquitinationFTKDQTEKEIDEIHS
EECCCCHHHHHHHHH
64.4623000965
341AcetylationEIDEIHSKYRKKHKS
HHHHHHHHHHHHCHH
34.6126051181
341UbiquitinationEIDEIHSKYRKKHKS
HHHHHHHHHHHHCHH
34.6123000965
344UbiquitinationEIHSKYRKKHKSEFQ
HHHHHHHHHCHHHHH
57.0223000965
345UbiquitinationIHSKYRKKHKSEFQL
HHHHHHHHCHHHHHH
47.4723000965
347SumoylationSKYRKKHKSEFQLLV
HHHHHHCHHHHHHHH
61.64-
347SumoylationSKYRKKHKSEFQLLV
HHHHHHCHHHHHHHH
61.64-
347UbiquitinationSKYRKKHKSEFQLLV
HHHHHHCHHHHHHHH
61.6423000965
348PhosphorylationKYRKKHKSEFQLLVD
HHHHHCHHHHHHHHH
43.2828555341
362UbiquitinationDQARKGYKKIAGMSQ
HHHHHHHHHHHCCCC
46.50-
363UbiquitinationQARKGYKKIAGMSQK
HHHHHHHHHHCCCCC
29.3429967540
368PhosphorylationYKKIAGMSQKTVTIT
HHHHHCCCCCEEEEE
27.8323403867
370SumoylationKIAGMSQKTVTITKE
HHHCCCCCEEEEECC
37.34-
370AcetylationKIAGMSQKTVTITKE
HHHCCCCCEEEEECC
37.3471255
370SumoylationKIAGMSQKTVTITKE
HHHCCCCCEEEEECC
37.34-
370UbiquitinationKIAGMSQKTVTITKE
HHHCCCCCEEEEECC
37.3422817900
375PhosphorylationSQKTVTITKEDESTE
CCCEEEEECCCCCCH
21.0023403867
376SumoylationQKTVTITKEDESTEK
CCEEEEECCCCCCHH
60.36-
376AcetylationQKTVTITKEDESTEK
CCEEEEECCCCCCHH
60.3626051181
376SumoylationQKTVTITKEDESTEK
CCEEEEECCCCCCHH
60.3628112733
376UbiquitinationQKTVTITKEDESTEK
CCEEEEECCCCCCHH
60.3621906983
380PhosphorylationTITKEDESTEKLSSV
EEECCCCCCHHHHHH
54.9420860994
383UbiquitinationKEDESTEKLSSVCMG
CCCCCCHHHHHHHCC
54.4821963094
385PhosphorylationDESTEKLSSVCMGQE
CCCCHHHHHHHCCCC
31.6220068231
386PhosphorylationESTEKLSSVCMGQED
CCCHHHHHHHCCCCC
29.7630576142
396PhosphorylationMGQEDNMTSVTNHFS
CCCCCCCHHHHHCCC
26.7120068231
397PhosphorylationGQEDNMTSVTNHFSQ
CCCCCCHHHHHCCCH
19.0430576142
399PhosphorylationEDNMTSVTNHFSQSK
CCCCHHHHHCCCHHH
23.8130576142
403PhosphorylationTSVTNHFSQSKLDSP
HHHHHCCCHHHCCCH
26.4517525332
405PhosphorylationVTNHFSQSKLDSPEE
HHHCCCHHHCCCHHH
33.7125159151
409PhosphorylationFSQSKLDSPEELEPD
CCHHHCCCHHHCCCC
44.6529255136
434PhosphorylationIQEVLSSSESDSCNS
HHHHHHCCCCCCCCC
37.4321098111
460PhosphorylationEEEAWEASHKNDLQD
HHHHHHHHHHCCCCC
24.3926074081
462UbiquitinationEAWEASHKNDLQDTE
HHHHHHHHCCCCCCC
50.0621906983
468O-linked_GlycosylationHKNDLQDTEISPRQN
HHCCCCCCCCCHHHC
23.4330379171
468PhosphorylationHKNDLQDTEISPRQN
HHCCCCCCCCCHHHC
23.4323927012
471PhosphorylationDLQDTEISPRQNRRT
CCCCCCCCHHHCHHH
14.0619664994
478PhosphorylationSPRQNRRTRAAESAE
CHHHCHHHHHHHHHC
22.7926074081
483PhosphorylationRRTRAAESAEIEPRN
HHHHHHHHHCCCCCC
26.8625218447

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
99SPhosphorylationKinaseCDK2P24941
PSP
403SPhosphorylationKinaseATMQ13315
PSP
434SPhosphorylationKinaseCDC7O00311
PSP
-KUbiquitinationE3 ubiquitin ligaseRAD18Q9NS91
PMID:15509568

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of RAD18_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RAD18_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
UBE2A_HUMANUBE2Aphysical
10908344
UBE2B_HUMANUBE2Bphysical
10908344
UBE2A_HUMANUBE2Aphysical
10884424
UBE2B_HUMANUBE2Bphysical
10884424
RAD51_HUMANRAD51physical
19396164
TP53B_HUMANTP53BP1physical
19228710
FACD2_HUMANFANCD2physical
21355096
FANCI_HUMANFANCIphysical
21355096
FACD2_HUMANFANCD2physical
20967207
PCNA_HUMANPCNAphysical
20675655
CDC7_HUMANCDC7physical
21098111
POLH_HUMANPOLHphysical
21098111
UBE2B_HUMANUBE2Bphysical
21422291
UBE2A_HUMANUBE2Aphysical
21858012
UBE2B_HUMANUBE2Bphysical
21858012
PCNA_HUMANPCNAphysical
21858012
H2A1A_HUMANHIST1H2AAphysical
21858012
PCNA_HUMANPCNAphysical
20600238
PCNA_HUMANPCNAphysical
20064529
NBN_HUMANNBNphysical
21884979
SLF1_HUMANANKRD32physical
22036607
PCNA_HUMANPCNAphysical
15359278
POLH_HUMANPOLHphysical
15359278
HLTF_HUMANHLTFphysical
21396873
SHPRH_HUMANSHPRHphysical
21396873
SHPRH_MOUSEShprhphysical
21396873
RAD18_HUMANRAD18physical
21396873
POLH_HUMANPOLHphysical
21396873
POLK_HUMANPOLKphysical
21396873
RAD18_HUMANRAD18physical
21549715
UBE2B_HUMANUBE2Bphysical
21549715
PCNA_HUMANPCNAphysical
17720710
UBE2B_HUMANUBE2Bphysical
17720710
PCNA_HUMANPCNAphysical
21227930
SPRTN_HUMANSPRTNphysical
22681887
ORC2_HUMANORC2physical
22681887
PCNA_HUMANPCNAphysical
21967848
UBE2A_HUMANUBE2Aphysical
18926833
RAD18_HUMANRAD18physical
15509568
POL_HV1H2gag-polphysical
12016221
WRIP1_HUMANWRNIP1physical
19556710
PCNA_HUMANPCNAphysical
17108083
UBE2A_HUMANUBE2Aphysical
22456510
DPOLN_HUMANPOLNphysical
22456510
RFC2_HUMANRFC2physical
18245774
PCNA_HUMANPCNAphysical
18245774
SPRTN_HUMANSPRTNphysical
22902628
CBPD_HUMANCPDphysical
22902628
UBE2B_HUMANUBE2Bphysical
20675655
UBE2A_HUMANUBE2Aphysical
17108083
UBE2B_HUMANUBE2Bphysical
18245774
UBE2B_HUMANUBE2Bphysical
20064529
RL10A_HUMANRPL10Aphysical
22939629
SLF1_MOUSEAnkrd32physical
15632077
POLH_HUMANPOLHphysical
23345618
PCGF6_HUMANPCGF6physical
22493164
TRIM8_HUMANTRIM8physical
22493164
BRCA1_HUMANBRCA1physical
23901102
DBF4A_HUMANDBF4physical
24240236
UBP5_HUMANUSP5physical
24454762
LTP_EBVB9BPLF1physical
24672041
UBE2A_HUMANUBE2Aphysical
24672041
RAD18_HUMANRAD18physical
24672041
UBC_HUMANUBCphysical
17550899
SIVA_HUMANSIVA1physical
24958773
PCNA_HUMANPCNAphysical
24958773
UBE2B_HUMANUBE2Bphysical
24958773
SHPRH_HUMANSHPRHphysical
25023518
HLTF_HUMANHLTFphysical
25023518
RAD18_HUMANRAD18physical
25023518
UBC_HUMANUBCphysical
25162118
PCNA_HUMANPCNAphysical
22904075
UBE2A_HUMANUBE2Aphysical
22904075
UBC_HUMANUBCphysical
20935496
UBC_HUMANUBCphysical
22742833
UBC_HUMANUBCphysical
22343915
CREM_HUMANCREMphysical
26496610
HXK2_HUMANHK2physical
26496610
ITSN1_HUMANITSN1physical
26496610
UBE2A_HUMANUBE2Aphysical
26496610
SRGP3_HUMANSRGAP3physical
26496610
TNPO3_HUMANTNPO3physical
26496610
LIN7C_HUMANLIN7Cphysical
26496610
SLF2_HUMANFAM178Aphysical
26496610
SRGP1_HUMANSRGAP1physical
26496610
ATPF1_HUMANATPAF1physical
26496610
SLF1_HUMANANKRD32physical
26496610
CAVN1_HUMANPTRFphysical
26496610
UBC_HUMANUBCphysical
25756347
UBP7_HUMANUSP7physical
25961918
PCNA_HUMANPCNAphysical
26170230
UBE2A_HUMANUBE2Aphysical
26170230
REV1_MOUSERev1physical
26795561
UBC12_HUMANUBE2Mphysical
28831681
PCNA_HUMANPCNAphysical
28831681
UBE2B_HUMANUBE2Bphysical
27569044

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RAD18_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99; SER-103; SER-322 ANDSER-471, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-158; SER-164 ANDSER-471, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99; SER-103; THR-118;SER-158 AND SER-164, AND MASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99 AND SER-107, AND MASSSPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-409 AND SER-471, ANDMASS SPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-403, AND MASSSPECTROMETRY.
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99; SER-409 AND SER-471,AND MASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-118 AND SER-471, ANDMASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99 AND SER-471, AND MASSSPECTROMETRY.

TOP